Rett Syndrome Research Trust Joins the Bespoke Gene Therapy Consortium

Rett Syndrome Research Trust Joins the Bespoke Gene Therapy Consortium

Post Views: 110 The Rett Syndrome Research Trust (RSRT) has joined the Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP®BGTC), a public-private collaboration led by the Foundation for the National Institutes of Health (FNIH) and the National Institutes of Health (NIH), intended to accelerate new gene therapies for patients with rare diseases. RSRT is one…